Eagle Bay Advisors’s Vor Biopharma VOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-150
| Closed | -$167 | – | 924 |
|
|
2024
Q4 | $167 | Hold |
150
| – | – | ﹤0.01% | 984 |
|
|
2024
Q3 | $105 | Hold |
150
| – | – | ﹤0.01% | 1336 |
|
|
2024
Q2 | $150 | Hold |
150
| – | – | ﹤0.01% | 973 |
|
|
2024
Q1 | $356 | Hold |
150
| – | – | ﹤0.01% | 951 |
|
|
2023
Q4 | $338 | Hold |
150
| – | – | ﹤0.01% | 804 |
|
|
2023
Q3 | $318 | Hold |
150
| – | – | ﹤0.01% | 824 |
|
|
2023
Q2 | $464 | Hold |
150
| – | – | ﹤0.01% | 814 |
|
|
2023
Q1 | $807 | Hold |
150
| – | – | ﹤0.01% | 834 |
|
|
2022
Q4 | $998 | Hold |
150
| – | – | ﹤0.01% | 808 |
|
|
2022
Q3 | $1K | Hold |
150
| – | – | ﹤0.01% | 870 |
|
|
2022
Q2 | $746 | Buy |
+150
| New | +$746 | ﹤0.01% | 887 |
|
|
2022
Q1 | – | Sell |
-150
| Closed | -$2K | – | 945 |
|
|
2021
Q4 | $2K | Buy |
+150
| New | +$2K | ﹤0.01% | 915 |
|
|
2021
Q3 | – | Sell |
-150
| Closed | -$3K | – | 1117 |
|
|
2021
Q2 | $3K | Buy |
+150
| New | +$3K | ﹤0.01% | 806 |
|